CAS ID: | 14636-12-5 |
Molecular Formula: | C52H74N16O15S2 |
Molecular Weight: | 1227.4 g/mol |
Monoisotopic Mass: | 1226.496 g/mol |
Class: | Peptide |
Natural Product: | No |
Other Names: | TERLIPRESSIN | VARIQUEL |
Analysis: | Drug repositioning mechanism analysis |
InChI: | InChI=1S/C52H74N16O15S2/c53-17-5-4-9-31(45(76)60-23-41(57)72)63-51(82)38-10-6-18-68(38)52(83)37-27-85-84-26-36(61-44(75)25-59-43(74)24-58-42(73)22-54)50(81)65-34(20-29-11-13-30(69)14-12-29)48(79)64-33(19-28-7-2-1-3-8-28)47(78)62-32(15-16-39(55)70)46(77)66-35(21-40(56)71)49(80)67-37/h1-3,7-8,11-14,31-38,69H,4-6,9-10,15-27,53-54H2,(H2,55,70)(H2,56,71)(H2,57,72)(H,58,73)(H,59,74)(H,60,76)(H,61,75)(H,62,78)(H,63,82)(H,64,79)(H,65,81)(H,66,77)(H,67,80)/t31-,32-,33-,34-,35-,36-,37-,38-/m0/s1 | See All |
InChI Key: | BENFXAYNYRLAIU-QSVFAHTRSA-N | |
Smiles: | C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)NC(CCCCN)C(=O)NCC(=O)N | See All |
Molfile: | Download |
Trial Record 1
ClinicalTrial ID | NCT03144713 | Disease | Liver fibrosis |
Phase | Not Applicable | Status | Completed |
First Received | May 9, 2017 | Last Verified | September 5, 2018 |
Sponsor | Institute of Liver and Biliary Sciences, India |
Trial Record 2
ClinicalTrial ID | NCT00986817 | Disease | Liver fibrosis |
Phase | Phase 3 | Status | Completed |
First Received | September 30, 2009 | Last Verified | June 15, 2015 |
Sponsor | Assistance Publique - Hôpitaux de Paris |
Trial Record 3
ClinicalTrial ID | NCT00966355 | Disease | Fibrosis |
Phase | Phase 4 | Status | Completed |
First Received | August 26, 2009 | Last Verified | March 19, 2018 |
Sponsor | Korea University |
Trial Record 4
ClinicalTrial ID | NCT03107091 | Disease | Liver fibrosis |
Phase | Phase 2 | Status | Recruiting |
First Received | April 11, 2017 | Last Verified | January 18, 2018 |
Sponsor | BioVie Inc. |
Trial Record 5
ClinicalTrial ID | NCT00534677 | Disease | Liver fibrosis |
Phase | Phase 4 | Status | Completed |
First Received | September 26, 2007 | Last Verified | December 5, 2007 |
Sponsor | Aga Khan University |
Trial Record 6
ClinicalTrial ID | NCT00115947 | Disease | Liver fibrosis |
Phase | Phase 2,Phase 3 | Status | Completed |
First Received | June 27, 2005 | Last Verified | March 9, 2006 |
Sponsor | Hvidovre University Hospital |
Trial Record 7
ClinicalTrial ID | NCT02468063 | Disease | Liver fibrosis |
Phase | Not Applicable | Status | Completed |
First Received | June 10, 2015 | Last Verified | November 6, 2017 |
Sponsor | Institute of Liver and Biliary Sciences, India |
Trial Record 8
ClinicalTrial ID | NCT01836224 | Disease | Liver fibrosis |
Phase | Not Applicable | Status | Completed |
First Received | April 19, 2013 | Last Verified | November 22, 2016 |
Sponsor | Institute of Liver and Biliary Sciences, India |
Trial Record 9
ClinicalTrial ID | NCT00628160 | Disease | Liver fibrosis |
Phase | Phase 2,Phase 3 | Status | Completed |
First Received | March 4, 2008 | Last Verified | February 24, 2016 |
Sponsor | Hospital Clinic of Barcelona |
Trial Record 10
ClinicalTrial ID | NCT01640964 | Disease | Liver fibrosis |
Phase | Phase 2 | Status | Completed |
First Received | July 16, 2012 | Last Verified | March 15, 2016 |
Sponsor | Novartis Pharmaceuticals |
Trial Record 11
ClinicalTrial ID | NCT00742690 | Disease | Liver fibrosis |
Phase | Phase 2,Phase 3 | Status | Unknown |
First Received | August 28, 2008 | Last Verified | October 15, 2014 |
Sponsor | University of Padova |
Trial Record 12
ClinicalTrial ID | NCT00742339 | Disease | Liver fibrosis |
Phase | Phase 2,Phase 3 | Status | Terminated |
First Received | August 27, 2008 | Last Verified | October 15, 2014 |
Sponsor | University of Padova |
Trial Record 13
ClinicalTrial ID | NCT00287664 | Disease | Liver fibrosis |
Phase | Phase 4 | Status | Suspended |
First Received | February 7, 2006 | Last Verified | April 11, 2007 |
Sponsor | Hospital Clinic of Barcelona |
PubChem: | 72081 |
ChEMBL: | CHEMBL2135460 |